Platelet-rich fibrin (PRF) gel for chronic leg ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase interventional study will apply autologous platelet-rich fibrin (PRF) gel dressings to patients with non-infected chronic leg ulcers and follow wound healing over time. Wound severity and treatment response will be measured using the Bates-Jensen Wound Assessment Tool (BWAT) at scheduled visits. Eligible participants are adults older than 35, while those with infected ulcers, sepsis, or immunosuppression are excluded. The trial is single-center and conducted at Pak Emirates Military Hospital in Rawalpindi.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.

Exclusion Criteria:

* Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.

Where it's running

• Pak Emirates Military Hospital
  Rawalpindi, Punjab Province, Pakistan Recruiting

Study contacts

• Principal investigator: Prof. Moizza Tahir, MBBS, FCPS, FRCP — Pak Emirates Military Hospital
• Study coordinator: Ahsan Tameez Ud Din, MBBS
• Email: ahsantameezuddinmalik@gmail.com
• Phone: (+92 051) 9273480

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Miro3D Wound Matrix to Heal Diabetic Foot Ulcers

  This study is testing if adding a special wound dressing called Miro3D to regular care can help people with early-stage diabetic foot ulcers heal faster.

  Recruiting Reprise Biomedical, Inc. · Coconut Creek, Florida and 2 other locations · NCT06939686

• MIMOSA Pro near-infrared tissue oxygen imaging compared with standard leg vascular tests

  This project tries to see if the MIMOSA Pro near‑infrared camera can measure leg tissue oxygen as well as standard vascular tests in adults having lower‑limb vascular assessments.

  Recruiting MIMOSA Diagnostics Inc. · Lake Success, New York · NCT06899113

• Tropocells autologous platelet-rich fibrin for healing mild-to-moderate neuroischemic diabetic foot ulcers

  This will test whether Tropocells autologous platelet-rich fibrin (PRF) helps close mild-to-moderate neuroischemic diabetic foot ulcers in adults with type 1 or type 2 diabetes.

  Recruiting at 2 sites Phase 2 Estar Medical dba Medical Technologies, LTD · Corpus Christi, Texas and 1 other locations · NCT06810726

• PAW-hydrogel to help chronic wounds like diabetic foot and leg ulcers heal faster

  This trial will test whether a plasma-activated water–infused Carbopol® 940 hydrogel helps adults with long-standing wounds (diabetic foot, pressure, venous, arterial, or dehiscent ulcers) heal faster and have less bacteria compared with standard advanced wound care.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07541196

• GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study

  This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.

  Recruiting at 4 sites W.L.Gore & Associates · Darien, Connecticut and 3 other locations · NCT07538609

• Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers

  This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.

  Recruiting BioLab Holdings · Philidelphia, Pennsylvania · NCT07364630

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.